Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain. METHODS: We conducted a population-based case-control study of major coronary events (i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls. Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart. RESULTS: The overall average of the mean doses to the whole heart was 4.9 Gy (range, 0.03 to 27.72). Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray (95% confidence interval, 2.9 to 14.5; P<0.001), with no apparent threshold. The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy. The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy. CONCLUSIONS: Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease. The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years. Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. (Funded by Cancer Research UK and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence shows risk at lower doses (<0.5 Gy), with an estimated latency of 10 years or more29–31.”
From Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars (2020) · cites this paper as [29]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
(2011) · The Lancet · doi:10.1016/s0140-6736(11)61629-2 · Cited by 3,937
Self-citationCardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
The completeness of the Swedish Cancer Register – a sample survey for year 1998
Barlow, L., Westergren, K., Holmberg, L., & Talbäck, M. (2009) · Acta Oncologica · doi:10.1080/02841860802247664 · Cited by 1,236
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Self-citationDarby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Self-citationLifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Jones B, 2001, Clin Oncol (R Coll Radiol), 13, 71
Cited by
Items 301–400 of 1,001
Zagar, T. M., Kaidar‐Person, O., Tang, X., Jones, E. E., Matney, J. E., Das, S. K., Green, R. L., Sheikh, A., Khandani, A. H., McCartney, W. H., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.12.017 · Cited by 82
Management of Cardiovascular Disease in Women With Breast Cancer
Barish, R. M. B., Lynce, F. C., Unger, K. R., & Barac, A. (2019) · Circulation · doi:10.1161/circulationaha.118.039371 · Cited by 81
Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate
Poortmans, P. M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60192-6 · Cited by 89
Combination Antifungal Therapy for Cryptococcal Meningitis
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1305981 · Cited by 78
Statin Adherence: Does Gender Matter?
Goldstein, K. M., Zullig, L. L., Bastian, L. A., & Bosworth, H. B. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0619-9 · Cited by 82
Short and long term radiation induced cardiovascular disease in patients with cancer
Nielsen, K. M., Offersen, B. V., Nielsen, H. M., Vaage‐Nilsen, M., & Yusuf, S. W. (2017) · Clinical Cardiology · doi:10.1002/clc.22634 · Cited by 79
“Development of CAD is related to the age of the patient, proximity of the tumor to the heart, radiation dose, and presence of coexisting risk factors.(5) Treatment of radiation-induced CAD is similar to general population,(2) although the risk of restenosis in these patients is higher than usual.”
BackgroundInfluentialKarpf, D., Sakka, M., Metzger, M., & Grabenbauer, G. G. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1363-4 · Cited by 82
Hypofractionated radiation therapy for early breast cancer
Hickey, B. E., James, M. L., Lehman, M., Hider, P. N., Jeffery, M., Francis, D. P., & See, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003860.pub4 · Cited by 89
Cardiovascular Risks Associated with Low Dose Ionizing Particle Radiation
Yan, X., Sasi, S. P., Gee, H., Lee, J., Yang, Y., Mehrzad, R., Onufrak, J., Song, J., Enderling, H., Agarwal, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110269 · Cited by 76
“72 Gy) [7].”
Epidemiology, Traditional and Novel Risk Factors in Coronary Artery Disease
Mack, M. C., & Gopal, A. (2015) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.002 · Cited by 88
“Mediastinal or chest wall radiation during treatment for malignancy (eg, Hodgkin lymphoma or breast cancer) has been linked to CAD, pericardial disease, valvular disease, and cardiomyopathy.(115,116) Radiation CAD tends to involve the ostia of the left main and right coronary arteries, and may present as either angina…”
BackgroundRadiation Matters of the Heart: A Mini Review
Menezes, K. M., Wang, H., Hada, M., & Saganti, P. B. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00083 · Cited by 81
“(12) Ischemic heart disease Cholesterol plaque build-up”
Roos, C. T. G., van den Bogaard, V. A. B., Greuter, M. J. W., Vliegenthart, R., Schuit, E., Langendijk, J. A., van der Schaaf, A., Crijns, A. P. G., & Maduro, J. H. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.10.009 · Cited by 80
Cardiotoxicity of cancer chemotherapy in clinical practice
Jain, D., & Aronow, W. S. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1530831 · Cited by 77
Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer
Meehan, J., Gray, M., Martínez-Pérez, C., Kay, C., Pang, L. Y., Fraser, J. A., Poole, A. V., Kunkler, I. H., Langdon, S. P., Argyle, D. J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00628 · Cited by 83
“Cardiovascular side effects are a major concern for clinicians treating BC patients with RT (160, 161), especially for left sided BC or patients with pre-existing cardiovascular disease.”
BackgroundCoronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer
Carlson, L. E., Watt, G. P., Tonorezos, E. S., Chow, E. J., Yu, A. F., Woods, M., Lynch, C. F., John, E. M., Mellemkjær, L., Brooks, J. D., et al. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.07.008 · Cited by 92
Contemporary Breast Radiotherapy and Cardiac Toxicity
Yeboa, D. N., & Evans, S. B. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2015.09.003 · Cited by 77
Gomez, D. R., Yusuf, S. W., Munsell, M. F., Welsh, J. W., Liao, Z. X., Lin, S. H., Pan, H. Y., Chang, J. Y., Komaki, R. K., Cox, J. D., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000306 · Cited by 77
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?
Tommasi, C., Balsano, R., Corianò, M., Pellegrino, B., Saba, G., Bardanzellu, F., Denaro, N., Ramundo, M., Toma, I., Fusaro, A., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237239 · Cited by 76
Other Side of Breast Cancer: Factors Associated with Caregiver Burden
Vahidi, M., Mahdavi, N., Asghari, E., Ebrahimi, H., Eivazi Ziaei, J., Hosseinzadeh, M., Namdar Areshtanab, H., & Kermani, I. A. (2016) · Asian Nursing Research · doi:10.1016/j.anr.2016.06.002 · Cited by 76
“Breast cancer is the most common cancer in women worldwide [1].”
Heart Disease Mortality in the Life Span Study, 1950–2008
Takahashi, I., Shimizu, Y., Grant, E. J., Cologne, J., Ozasa, K., & Kodama, K. (2017) · Radiation Research · doi:10.1667/rr14347.1 · Cited by 76
The connection between the breast and heart in a woman: Breast cancer and cardiovascular disease
Gulati, M., & Mulvagh, S. L. (2018) · Clinical Cardiology · doi:10.1002/clc.22886 · Cited by 82
“001).(18) The increased risk started within the first 5 years after radiation therapy, and those with more cardiovascular risk factors had an increased risk of cardiovascular events, but the proportional increase of cardiovascular events by radiation dosage was the same.”
BackgroundMeattini, I., Poortmans, P. M., Marrazzo, L., Desideri, I., Brain, E. G. C., Hamaker, M. E., Lambertini, M., Miccinesi, G., Russell, N. S., Saieva, C., et al. (2020) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.07.013 · Cited by 76
Lorenzen, E. L., Rehammar, J. C., Jensen, M., Ewertz, M., & Brink, C. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.08.007 · Cited by 77
Self-citationKwan, M. L., Cheng, R. K., Iribarren, C., Neugebauer, R. S., Rana, J. S., Nguyen‐Huynh, M. N., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01738 · Cited by 77
“01 Never smoker 8,182 (55) 40,240 (54) Former smoker 4,282 (29) 16,506 (22) Current smoker 1,331 (9) 6,848 (9) Unknown 1,147 (8) 11,108 (15) Postmenopausal 11,224 (75) 56,659 (76) .”
Cancer Therapy-Induced Cardiotoxicity—A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy
Choksey, A., & Timm, K. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010441 · Cited by 76
“Though the incidence varies depending on the specific malignancy and dose of radiotherapy used, RIHD has been widely reported in Hodgkin’s lymphoma [77] and breast cancer [78,79].”
BackgroundLin, L., Souris, K., Kang, M., Glick, A., Lin, H., Huang, S., Stützer, K., Janssens, G., Sterpin, E., Lee, J. A., et al. (2016) · Medical Physics · doi:10.1002/mp.12040 · Cited by 76
“Major cardiac events have been associated with mean heart dose.(5) Thus, accurate representation and uncertainties in dose to liver and heart should be assessed in proton therapy and minimized with motion mitigation strategies.”
BackgroundAdverse Effects Of Radiation Therapy
Majeed, H., & Gupta, V. (2021) · StatPearls · Cited by 75
Screening for Coronary Artery Disease in Cancer Survivors
Velusamy, R., Nolan, M. T., Murphy, A. J., Thavendiranathan, P., & Marwick, T. H. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.12.007 · Cited by 90
Girinsky, T., M’kacher, R., Lessard, N., Koscielny, S., Elfassy, E., Raoux, F., Carde, P. P., Santos, M. A., Margainaud, J.-P., Sabatier, L., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.01.021 · Cited by 79
Liu, C., Schild, S. E., Chang, J. Y., Liao, Z. X., Korte, S. M., Shen, J., Ding, X., Hu, Y., Kang, Y., Keole, S. R., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.02.009 · Cited by 75
“Heart dose has been found as an independent dosimetric predictor of overall survival in patients with locally advanced NSCLC (63, 64).”
BackgroundKirkham, A. A., Beaudry, R. I., Paterson, D. I., Mackey, J. R., & Haykowsky, M. J. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.02.002 · Cited by 86
DeCesaris, C. M., Rice, S. R., Bentzen, S. M., Jatczak, J., Mishra, M. V., & Nichols, E. M. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.04.015 · Cited by 74
Sanmamed, N., Alcántara, P., Cerezo, E., Gaztañaga, M., Cabello, N., Gómez-Peña, S., Bustos, A., Doval, A., Corona, J. A., Rodriguez, G., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.11.049 · Cited by 74
“4% for each Gy of mean heart dose.(16) The mean dose to the heart in our study was 0.”
BackgroundTanguturi, S. K., Lyatskaya, Y., Chen, Y., Catalano, P. J., Chen, M. H., Yeo, W.-P., Marques, A., Truong, L., Yeh, M. J., Orlina, L. T., et al. (2015) · Practical Radiation Oncology · doi:10.1016/j.prro.2015.06.002 · Cited by 79
Radiation-induced heart disease: A practical guide to diagnosis and management
Donnellan, E., Phelan, D. M. J., McCarthy, C. P., Collier, P. H., Desai, M. Y., & Griffin, B. P. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.15104 · Cited by 74
“14 The distribution of atherosclerotic coronary arteries correlates well with the areas exposed to the highest doses of radiation.”
BackgroundZhu, Q., Kirova, Y., Cao, L., Arsene-Henry, A., & Chen, J. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.03.008 · Cited by 77
Real-world evidence research based on big data: Motivation—challenges—success factors
Maissenhälter, B., Woolmore, A. L., & Schlag, P. M. (2018) · Der Onkologe · doi:10.1007/s00761-018-0358-3 · Cited by 76
“Other examples for the complementarity of RCTs and RWE studies are longterm studies on treatment safety [6] or on topics for which RCTs were not feasible (especially for patients with a rare tumor) [23].”
BackgroundZhang, T. W., Snir, J. A., Boldt, G., Rodrigues, G., Louie, A. V., Gaede, S., McGarry, R. C., Urbanic, J. J., Daly, M. E., & Palma, D. A. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.12.044 · Cited by 74
Scott, J. M., Thomas, S. M., Peppercorn, J. M., Herndon, J. E., Douglas, P. S., Khouri, M. G., Dang, C. T., Yu, A. F., Catalina, D., Ciolino, C., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.043483 · Cited by 79
“Memorial Sloan Kettering Cancer Center 59 (34) 19 (33) 20 (35) 20 (34)”
Thor, M., Deasy, J. O., Hu, C., Gore, E., Bar‐Ad, V., Robinson, C. G., Wheatley, M., Oh, J. H., Bogart, J. A., Garces, Y. I., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2627 · Cited by 73
“Lower lobe (ref) 93 (21) 70 (23) 24 (18) 0.”
ResultBreast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship
Bodai, B. I., & Nakata, T. E. (2020) · The Permanente Journal · doi:10.7812/tpp/19.129 · Cited by 74
Ueda, K., Sakai, C., Ishida, T., Morita, K., Kobayashi, Y., Horikoshi, Y., Baba, A., Okazaki, Y., Yoshizumi, M., Tashiro, S., et al. (2023) · Clinical Science · doi:10.1042/cs20220525 · Cited by 79
Samson, P. P., Robinson, C. G., Bradley, J. D., Lockhart, A. C., Puri, V., Broderick, S., Kreisel, D., Krupnick, A. S., Patterson, G. A., Meyers, B. F., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.07.031 · Cited by 74
Development and evaluation of radiotherapy deep learning dose prediction models for breast cancer
Bakx, N., Bluemink, H., Hagelaar, E., van der Sangen, M., Theuws, J. C. M., & Hurkmans, C. (2021) · Physics and Imaging in Radiation Oncology · doi:10.1016/j.phro.2021.01.006 · Cited by 72
“For major coronary events, Darby et al. found an excess relative risk (ERR) of 7.4% per Gy mean heart dose (MHD) [3], whereas Taylor et al. found an ERR of 4.1% per Gy MHD for cardiac mortality alone and an ERR of 11% per Gy mean lung dose (MLD) for mortality resulting from RT induced lung cancer…”
BackgroundInfluentialSárközy, M., Varga, Z., Gáspár, R., Szűcs, G., Kovács, M. G., Kovács, Z. Z. A., László, A., Kahán, Z., & Csont, T. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01809-y · Cited by 82
Complications of thoracic radiotherapy
Chargari, C., Riet, F. G., Mazevet, M., Morel, É., Pechoux, C. L., & Deutsch, É. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.06.012 · Cited by 83
“provided further insights on the risk of ischemic coronary heart disease in a large cohort of breast cancer patients receiving radiotherapy [72].”
BackgroundDyhl-Polk, A., Shahmarvand, N., Vistisen, K. K., Vaage‐Nilsen, M., Larsen, F. O., Schou, M., & Nielsen, D. L. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012798 · Cited by 72
“38 In our study, the mean time from chest irradiation to capecitabine start was 4 years.”
Wang, J., Hu, W., Yang, Z., Chen, X., Wu, Z., Yu, X., Guo, X., Lu, S., Li, K., & Yu, G. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0822-z · Cited by 72
“However, looking over the studies [30, 33] of radiation-related heart disease of breast cancer patients and atomic bomb survivors, there are no known “safe” levels of radiation to the heart.”
BackgroundGallo, M., Muscogiuri, G., Felicetti, F. C., Faggiano, A., Trimarchi, F., Arvat, E., Vigneri, R., & Colao, A. (2017) · Metabolism · doi:10.1016/j.metabol.2017.09.013 · Cited by 76
Mattioli, A. V., Sciomer, S., Moscucci, F., Maiello, M. R., Cugusi, L., Gallina, S., Dei, A., Lombardi, C., Pengo, M. F., Parati, G., et al. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000831 · Cited by 74
Vo, J. B., Ramin, C. A., Veiga, L. H. S., Brandt, C., Curtis, R. E., Bodelón, C., Barac, A., Roger, V. L., Feigelson, H. S., Buist, D. S. M., et al. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae107 · Cited by 71
Zellars, R. C., Bravo, P. E., Tryggestad, E. J., Hopfer, K., Myers, L. T., Tahari, A. K., Asrari, F., Ziessman, H. A., & Garrett-Mayer, E. S. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.12.035 · Cited by 71
Bosch, D. J., Muijs, C. T., Mul, V. E. M., Beukema, J. C., Hospers, G. A. P., Burgerhof, J. G. M., & Plukker, J. T. M. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3316-8 · Cited by 71
Sisler, J. J., Chaput, G., SUSSMAN, J. S., & Ozokwelu, E. (2016) · PubMed Central · Cited by 80
Saiki, H., Moulay, G., Guenzel, A. J., Liu, W., Decklever, T. D., Classic, K. L., Pham, L., Chen, H. H., Burnett, J. C. J., Russell, S. J., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00124.2017 · Cited by 76
“heart failure with preserved ejection fraction; diastolic dysfunction; animal model; radiation; coronary microvasculature THE HIGH DOSES OF THORACIC RADIATION used with radiotherapy for some thoracic tumors and with older breast cancer radiotherapy techniques increase the risk of cardiac disease (9, 50, 51, 54).”
Pierce, L. J., Feng, M. U.-S., Griffith, K. A., Jagsi, R., Boike, T. P., Dryden, D., Gustafson, G. S., Benedetti, L., Matuszak, M. M., Nurushev, T. S., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.07.022 · Cited by 74
“This is especially true because Darby et al (5) have demonstrated a dose-response relationship between the heart dose and major coronary events.”
BackgroundOvergaard, M., Nielsen, H. M., Tramm, T., Højris, I., Grantzau, T. L., Alsner, J., Offersen, B. V., & Overgaard, J. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.03.008 · Cited by 70
“The latter has recently drawn significant attention and has become a major factor in the discussion of the indication for, and the applied technique in breast cancer radiotherapy [20,21].”
BackgroundHoppe, B. S., Flampouri, S., Zaiden, R. A., Slayton, W. B., Sandler, E. S., Ozdemir, S., Dang, N. H., Lynch, J. W., Li, Z., Morris, C. G., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.04.029 · Cited by 70
Proton therapy for paediatric CNS tumours — improving treatment-related outcomes
Gondi, V., Yock, T. I., & Mehta, M. P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.70 · Cited by 76
Jensen, C. A., Roa, A. M. A., Johansen, M., Lund, J., & Frengen, J. (2017) · Physica Medica · doi:10.1016/j.ejmp.2017.11.019 · Cited by 70
“reported that the rates of major coronary events increased linearly with the mean dose to the heart, and that there seems to be no lower dose threshold [2].”
BackgroundRadiation-Induced Cardiovascular Disease: Mechanisms and Importance of Linear Energy Transfer
Sylvester, C. B., Abe, J.-I., Patel, Z. S., & Grande-Allen, K. J. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00005 · Cited by 69
“(10) NF-κB activation from both pathways induces factors that lead to antiapoptotic, radiation”
BackgroundFerdinand, S., Mondal, M., Mallik, S., Goswami, J., Das, S., Manir, K. S., Sen, A., Palit, S., Sarkar, P., Mondal, S., et al. (2021) · Technical Innovations & Patient Support in Radiation Oncology · doi:10.1016/j.tipsro.2021.02.006 · Cited by 70
“A study by Darby et al [3] has shown that rates of major coronary events increase linearly by 7.”
BackgroundInfluentialHennequin, C., Belkacémi, Y., Bourgier, C., Cowen, D. M., Cutuli, B., Fourquet, A., Hannoun‐Lévi, J., Pasquier, D., Racadot, S., & Rivera, S. (2021) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2021.11.013 · Cited by 69
Ryan, T. D., Bates, J. E., Kinahan, K. E., Leger, K. J., Mulrooney, D. A., Narayan, H. K., Ness, K. K., Okwuosa, T. M., Rainusso, N. C., Steinberger, J., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001308 · Cited by 76
Zumsteg, Z. S., Riaz, N., Jaffery, S., Hu, M., Gelblum, D. Y., Zhou, Y., Mychalczak, B. R., Zeléfsky, M. J., Wolden, S. L., Rao, S. S. D., et al. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.02.003 · Cited by 69
“4% in the rate of major coronary artery events for each additional gray of mean heart radiation dose [7], it seems possible that a clinically significant decrease in carotid-associated adverse sequelae may potentially result from the magnitude of reduction in carotid-artery dose achievable with carotid sparing IMRT, p…”
BackgroundTsang, Y. M., Ciurlionis, L., Kirby, A. M., Locke, I., Venables, K., Yarnold, J. R., Titley, J. C., Bliss, J. M., Coles, C. E., & on behalf of the IMPORT Trial Management Group (2015) · British Journal of Radiology · doi:10.1259/bjr.20150453 · Cited by 69
Lin, W., Huang, J., Yuan, Z., Feng, S., Xie, Y., & Ma, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-02222-0 · Cited by 73
Cardiovascular effects of radiation therapy
Armanious, M. A., Mohammadi, H., Khodor, S., Oliver, D. E., Johnstone, P. A. S., & Fradley, M. G. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.05.008 · Cited by 70
Pandeli, C., Smyth, L. M. L., David, S., & See, A. W. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1430-x · Cited by 69
The Cardiovascular Perils of Cancer Survivorship
Moslehi, J. (2013) · New England Journal of Medicine · doi:10.1056/nejme1215300 · Cited by 67
Association of Breast Cancer Irradiation With Cardiac Toxic Effects: A Narrative Review
Meattini, I., Poortmans, P. M., Aznar, M. C., Becherini, C., Bonzano, E., Cardinale, D. M., Lenihan, D. J., Marrazzo, L., Curigliano, G., & Livi, L. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.7468 · Cited by 68
Nosrati, H., Seidi, F., Hosseinmirzaei, A., Mousazadeh, N., Mohammadi, A., Ghaffarlou, M., Danafar, H., Conde, J., & Sharafi, A. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102321 · Cited by 68
Towards Achieving the Full Clinical Potential of Proton Therapy by Inclusion of LET and RBE Models
Jones, B. (2015) · Cancers · doi:10.3390/cancers7010460 · Cited by 68
“5% per Gray [2], as well as the established cancer induction risks of at least 5% per Sievert [3], leads to a logical requirement for radiation beams that can markedly reduce integral dose and so the amount of tissue traversed.”
BackgroundInfluentialVerhoeven, K., Sweldens, C., Petillion, S., Laenen, A., Peeters, S., Janssen, H., Limbergen, E. V., & Weltens, C. G. (2013) · Practical Radiation Oncology · doi:10.1016/j.prro.2013.07.005 · Cited by 68
Lauche, O., Kirova, Y., Fenoglietto, P., Costa, E., Lemanski, C., Bourgier, C., Riou, O., Tiberi, D. A., Campana, F., Fourquet, A., et al. (2016) · World Journal of Radiology · doi:10.4329/wjr.v8.i8.735 · Cited by 68
Proton therapy for locally advanced breast cancer: A systematic review of the literature
Kammerer, E., Guévelou, J. L., Chaikh, A., Danhier, S., Geffrelot, J., Lévy, C., Saloux, É., Habrand, J., & Thariat, J. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.006 · Cited by 68
Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy
Chang, S., Liu, G., Zhao, L., Dilworth, J. T., Zheng, W., Jawad, S., Yan, D., Chen, P., Stevens, C. W., Kabolizadeh, P., et al. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01676-3 · Cited by 70
Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies
Díaz-Gavela, A. A., Figueiras-Graillet, L. M., Luis, A. M., Segura, J. S., Ciérvide, R., Peñalver, E. D. C., Couñago, F., Arenas, M., & López‐Fernández, T. (2021) · Cancers · doi:10.3390/cancers13071712 · Cited by 76
“Although its therapeutic management is the same as for conventional treatment (in patients with no prior RT), revascularization should be evaluated in the presence of acute coronary syndrome or myocardial infarction [9,20,22].”
BackgroundA Novel Approach to Postmastectomy Radiation Therapy Using Scanned Proton Beams
Depauw, N., Batin, E., Daartz, J., Rosenfeld, A. B., Adams, J., Kooy, H. M., MacDonald, S. M., & Lu, H. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.10.039 · Cited by 67
Nichols, E. M., Kesmodel, S. B., Bellavance, E. C., Drogula, C., Tkaczuk, K. H. R., Cohen, R. J., Citron, W. K., Morgan, M., Staats, P. N., Feigenberg, S. J., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.11.030 · Cited by 71
Verma, V., Iftekaruddin, Z., Badar, N., Hartsell, W. F., Chang, J. H.-C., Gondi, V., Pankuch, M., Gao, M., Schmidt, S. L., Kaplan, D., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.04.007 · Cited by 67
Kugele, M., Edvardsson, A., Berg, L., Alkner, S., Andersson-Ljus, C., & Ceberg, S. (2017) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.12214 · Cited by 75
“Adjuvant radiotherapy for breast cancer reduces the risk of locoregional recurrence as well as breast cancer death.1,2 However, some radiation is inevitably delivered to normal tissue, such as the heart and lungs, which has been shown to increase the risk of cardiovascular and pulmonary disease.3–9 Darby et al.5 have…”
BackgroundInfluentialDreyfuss, A. D., Goia, D., Shoniyozov, K., Shewale, S. V., Velalopoulou, A. P., Mazzoni, S., Avgousti, H., Metzler, S. D., Bravo, P. E., Feigenberg, S. J., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3882 · Cited by 67
Radiation Exposure and Mortality from Cardiovascular Disease and Cancer in Early NASA Astronauts
Elgart, S. R., Little, M. P., Chappell, L. J., Milder, C. M., Shavers, M. R., Huff, J. L., & Patel, Z. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-25467-9 · Cited by 66
Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary Intervention
Ueki, Y., Vögeli, B., Karagiannis, A., Zanchin, T., Zanchin, C., Rhyner, D., Otsuka, T., Praz, F., Siontis, G. C. M., Moro, C., et al. (2019) · JACC CardioOncology · doi:10.1016/j.jaccao.2019.11.001 · Cited by 67
Chung, S. Y., Oh, J., Chang, J. S., Shin, J., Kim, K. H., Chun, K., Keum, K. C., Suh, C., Kang, S., & Kim, Y. B. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.12.053 · Cited by 66
Radiothérapie du cancer du sein
Hennequin, C., Barillot, I., Azria, D., Belkacémi, Y., Bollet, M. A., Chauvet, B., Cowen, D. M., Cutuli, B., Fourquet, A., Hannoun‐Lévi, J., et al. (2016) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2016.07.025 · Cited by 81
Vaidya, J. S., Wenz, F. K., Bulsara, M. K., Tobias, J. S., Joseph, D. J., Saunders, C. M., Brew‐Graves, C., Potyka, I., Morris, S., Vaidya, H. J., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20730 · Cited by 72
“Indeed, a large recent study from a group from Oxford, UK, published in the New England Journal of Medicine, has shown that EBRT toxicity appears within the first 5 years.(71) The authors found an increase in cardiac mortality of 16.”
BackgroundBartlett, F. R., Donovan, E. M., McNair, H. A., Corsini, L., Colgan, R. M., Evans, P., Maynard, L., Griffin, C. L., Haviland, J., Yarnold, J. R., et al. (2016) · Clinical Oncology · doi:10.1016/j.clon.2016.11.005 · Cited by 66
Managing an Older Adult with Cancer: Considerations for Radiation Oncologists
Chang, S., Goldstein, N. E., & Dharmarajan, K. V. (2017) · BioMed Research International · doi:10.1155/2017/1695101 · Cited by 69
Reshko, L. B., Kalman, N. S., Hugo, G. D., & Weiss, E. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.04.42 · Cited by 70
Lanthanide-Doped Upconversion Nanocarriers for Drug and Gene Delivery
Lee, G., & Park, Y. I. (2018) · Nanomaterials · doi:10.3390/nano8070511 · Cited by 72
Lariviere, M. J., Santos, P. M. G., Hill‐Kayser, C. E., & Metz, J. M. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.08.006 · Cited by 66
Intraoperative Radiation Therapy: A Critical Analysis of the ELIOT and TARGIT Trials. Part 2—TARGIT
Silverstein, M. J., Fastner, G., Maluta, S., Reitsamer, R., Goer, D. A., Vicini, F. A., & Wazer, D. E. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3999-5 · Cited by 69
Current controversies in radiotherapy for breast cancer
Breast cancer expert panel of the German Society of Radiation Oncology (DEGRO), Krug, D. A., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R., Haase, W., Harms, W., Piroth, M. D., et al. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0766-3 · Cited by 70
“There is a clear dose–response relationship [53].”
Scott, J. G., Sedor, G., Scarborough, J. A., Kattan, M. W., Peacock, J. S., Grass, G. D., Mellon, E. A., Thapa, R., Schell, M. J., Waller, A. F., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.11.008 · Cited by 65
Benefits, risks, and safety of external beam radiation therapy for breast cancer
Halyard, M. Y., Brown, L. C., & Mutter, R. W. (2015) · International Journal of Women s Health · doi:10.2147/ijwh.s55552 · Cited by 88
“In 2013, Darby et al published a case-controlled study analyzing the risk of major coronary events (myocardial infarction, coronary revascularization, or death from ischemic heart disease) and again found that women with left-sided breast cancer had more major coronary events than those treated for right-sided breast…”
Rong, Y., Walston, S., Welliver, M. X., Chakravarti, A., & Quick, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097933 · Cited by 65
“coronary artery disease and myocardial infarction for women treated with radiation for left-sided breast cancer [6–8].”
BackgroundYe, J. C., Yan, W., Christos, P. J., Nori, D., & Ravi, A. (2015) · Clinical Breast Cancer · doi:10.1016/j.clbc.2015.03.012 · Cited by 73
Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer
Verma, V., Shah, C., & Mehta, M. P. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.02.006 · Cited by 66
Metadata
- Authors
- Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., Jensen, M.-B., Nisbet, A., Peto, R., Rahimi, K., Taylor, C., & Hall, P.
- Affiliations
- University of Oxford (GB)
- University of Southern Denmark (DK)
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Aalborg University Hospital (DK)
- University of South Florida (US)
- Danderyds sjukhus (SE)
- Rigshospitalet (DK)
- Royal Surrey County Hospital (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-14
- Volume
- 368
- Issue
- 11
- Pages
- 987-998
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154375587
- Cited by
- 3,974
- References
- 38
- Citations by year
- 2026: 277 · 2025: 290 · 2024: 270 · 2023: 358 · 2022: 359 · 2021: 392 · 2020: 344 · 2019: 285 · 2018: 278 · 2017: 268 · 2016: 285 · 2015: 259 · 2014: 195 · 2013: 107
- FWCI
- 191.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Cancer Research UK
- National Institute for Health and Care Research (RRX 108)
- British Heart Foundation (RE/08/004, CRE RE/08/004)
- University of Oxford (RE/08/004)
- European Commission
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Keywords
- breast cancer radiotherapy, ischemic heart disease, coronary events, myocardial infarction, coronary revascularization, radiation-induced heart disease, left anterior descending artery, radiation dose, cardiovascular risk factors, women
- MeSH terms
- Adult, Aged, Breast Neoplasms, Female, Heart, Humans, Mastectomy, Middle Aged, Radiation Injuries, Radiotherapy Dosage, Risk, Risk Factors, Case-Control Studies, Chemotherapy, Adjuvant, Myocardial Ischemia, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.